Trials & Tribulations LLS former CSO: Immunotherapy, precision medicine redefined blood cancer treatment February 07, 2025Vol.51 No.05By Lee Greenberger
Trials & Tribulations Physicians and biopharma should improve accessibility of cancer trials February 07, 2025Vol.51 No.05By Michel van Harten
Trials & Tribulations From clinician scientist to nonprofit CEO January 24, 2025Vol.51 No.03By E. Anders Kolb
Trials & Tribulations Chadi Nabhan: Why I wrote a book about cancer January 17, 2025Vol.51 No.02By Chadi Nabhan
FreeTrials & Tribulations New colorectal cancer screening strategies must advance the standard of care January 10, 2025Vol.51 No.01By Paul J. Limburg
Trials & Tribulations Menin inhibitors emerge as new treatment for advanced AML November 22, 2024Vol.50 No.44By Ghayas Issa
Trials & Tribulations How we improved the treatment of Hodgkin lymphoma November 15, 2024Vol.50 No.43By Alex Herrera
Trials & Tribulations A study measures the long-term downside of prostate cancer screeningA paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment November 08, 2024Vol.50 No.42By Otis W. Brawley
Trials & Tribulations Addressing high cancer mortality in Native Hawaiian and Pacific Islander populationsA call for equity in cancer research November 01, 2024Vol.50 No.41By Naoto T. Ueno
Trials & Tribulations Cancer clinical trials shouldn’t discriminate—but they do October 11, 2024Vol.50 No.38By Erin Miller
